QNTM
Quantum Biopharma-B Sub Vot
NASDAQ · Pharmaceuticals
$4.20
+0.28 (+7.14%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.92M | 6.74M |
| Net Income | 1.84M | 1.19M | 1.39M |
| EPS | — | — | — |
| Profit Margin | 24.2% | 17.2% | 20.6% |
| Rev Growth | +16.6% | +5.5% | +24.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 6.68M | 6.34M | 7.12M |
| Total Equity | 10.50M | 9.75M | 8.98M |
| D/E Ratio | 0.64 | 0.65 | 0.79 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 2.64M | 2.30M | 2.54M |
| Free Cash Flow | 1.03M | 1.07M | 803.7K |